Brain's Guardian Peptides Maintain Immune System Balance

Scientists at Washington University School of Medicine in St. Louis have uncovered a crucial mechanism by which the brain communicates with the immune system to maintain a delicate balance between defense and protection of healthy tissue. The study, published in Nature, reveals the role of "guardian peptides" produced by the brain and spinal cord in regulating immune responses.

These peptides, presented by immune cells at the brain's borders, attract and activate regulatory T cells that help suppress abnormal immune reactions. The researchers found that in healthy mice, brain proteins, particularly myelin sheath components, were abundantly presented by immune cells. However, in mice with multiple sclerosis (MS), these proteins were significantly reduced.

Lead research Jonathan Kipnis, explained, "We have found guardian brain peptides that actively engage with the immune system to keep it in check, possibly preventing destructive immune responses." The team demonstrated that injecting vesicles containing these missing brain-derived peptides into the cerebrospinal fluid of mice with MS activated suppressor T cells, improved motor function, and slowed disease progression.

This discovery opens new possibilities for treating neuroinflammatory and neurodegenerative diseases. Min Woo Kim, first author on the study, suggested that unique protein signatures presented to the immune system in various brain disorders could serve as early diagnostic tools. “We have identified a novel process in the brain where the organ actively engages with the immune system to present a healthy image of itself,” Kim said. “That image looks different in mice with multiple sclerosis. We think that other neuroinflammatory and even neurodegenerative diseases may have unique protein signatures presented to the immune system, opening the exciting possibility of using such signatures as a diagnostic tool for early diagnosis.”